Reuters logo
9 months ago
BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study
December 1, 2016 / 1:20 PM / 9 months ago

BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study

Dec 1 (Reuters) - Pfizer Inc:

* lyrica (pregabalin) phase 3 trial in pediatric epilepsy meets primary endpoint

* Lyrica is not approved as adjunctive therapy for pediatric epilepsy patients with partial onset seizures Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below